US Edition
Published • loading... • Updated
Anvisa Discusses Standard for Handling Slimming Pens
Summary by EBC
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
The collegiate board of the National Agency of Health Surveillance (Anvisa) discusses, on the next day 29, a proposal for normative instruction on procedures and technical requirements that will deal with the handling of drugs of the class of GLP 1 receptor agonists, popularly known as weight-loss pens. The new standard will be part of a set of strategies that integrate the action plan announced on the last day 6, consisting of regulatory and co…
·Quadra, Brazil
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
